Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Dec 10, 2014; 5(5): 901-907
Published online Dec 10, 2014. doi: 10.5306/wjco.v5.i5.901
Breast cancer as photodynamic therapy target: Enhanced therapeutic efficiency by overview of tumor complexity
María Julia Lamberti, Natalia Belén Rumie Vittar, Viviana Alicia Rivarola
María Julia Lamberti, Natalia Belén Rumie Vittar, Viviana Alicia Rivarola, Departamento de Biología Molecular, Facultad de Ciencias Exactas Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Córdoba, Río Cuarto 5800, Argentina
Author contributions: Lamberti MJ compiled and analyzed the data; Rumie Vittar NB and Rivarola VA organized the manuscript and contributed intellectually to this work.
Supported by funds provided by CONICET (PIP 112-201101-00453), SECyT, FONCyT (PICT 2011-1328), and MinCyT Córdoba (PID 2010)
Correspondence to: Dr. Viviana Alicia Rivarola, Professor of Biochemistry, Conicet research, Departamento de Biología Molecular, Facultad de Ciencias Exactas Físico-Químicas y Naturales, Universidad Nacional de Río Cuarto, Ruta 36, km 601, Córdoba, Río Cuarto 5800, Argentina. vrivarola@exa.unrc.edu.ar
Telephone: +54-35-84676437 Fax: +54-35-84676232
Received: December 24, 2013
Revised: April 4, 2014
Accepted: July 15, 2014
Published online: December 10, 2014
Abstract

Photodynamic therapy is a minimally invasive and clinically approved procedure for eliminating selected malignant cells with specific light activation of a photosensitizer agent. Whereas interstitial and intra-operative approaches have been investigated for the ablation of a broad range of superficial or bulky solid tumors such as breast cancer, the majority of approved photodynamic therapy protocols are for the treatment of superficial lesions of skin and luminal organs. This review article will discuss recent progress in research focused mainly on assessing the efficacies of various photosensitizers used in photodynamic therapy, as well as the combinatory strategies of various therapeutic modalities for improving treatments of parenchymal and/or stromal tissues of breast cancer solid tumors. Cytotoxic agents are used in cancer treatments for their effect on rapidly proliferating cancer cells. However, such therapeutics often lack specificity, which can lead to toxicity and undesirable side effects. Many approaches are designed to target tumors. Selective therapies can be established by focusing on distinctive intracellular (receptors, apoptotic pathways, multidrug resistance system, nitric oxide-mediated stress) and environmental (glucose, pH) differences between tumor and healthy tissue. A rational design of effective combination regimens for breast cancer treatment involves a better understanding of the mechanisms and molecular interactions of cytotoxic agents that underlie drug resistance and sensitivity.

Keywords: Photodynamic therapy, Breast cancer, Tumor microenvironment, Treatment combination, Synergism

Core tip: Breast cancer is the most common cancer in women worldwide. However, effective therapies that reduce the high mortality rate and improve patient quality of life are still unavailable. In recent years, the use of photodynamic therapy has been examined for use in breast cancer treatment. Photodynamic therapy provides a new and promising antitumor strategy that could be implemented, alone or in combination with other approved or experimental therapeutic approaches, to a wide range of applications.